Artificial intelligence (AI) can enhance insulin dosing accuracy for hospitalized patients with type 2 diabetes (T2D), ...

Roche nets European approval for AI-powered CGM in Type 1, Type 2 diabetes Roche unveiled its Accu-Chek SmartGuide continuous glucose monitor, equipped with artificial-intelligence-powered ...

Right now, it produces approximately 5.2 billion Accu-Chek diabetes test strips annually. Roche says it plans to invest $50 billion in pharmaceuticals and diagnostics in the United States over the ...

It houses research and development, laboratories, manufacturing and other functions, and produces Roche’s Accu-Chek diabetes test strips. The facility is one of two global distribution hubs for ...

Roche's Indianapolis campus has established itself as a hub for glucose monitors and diabetes research. The site produces approximately 5.2 billion Accu-Chek diabetes test strips each year and ...

The facility produces about 5.2 billion Accu-Chek diabetes test strips annually and serves as one of the company’s two global distribution hubs focused on serving the U.S. market and supporting ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site will serve as a hub for ...

system. The Indianapolis campus currently produces around 5.2B Accu-Chek diabetes test strips annually.

Accu-Chek Instant is known for being a simple, accurate, and reliable blood glucose monitoring system widely used by people living with diabetes. However, the genuine product has a shelf life of 21 ...